Try our Advanced Search for more refined results

January 20, 2023

Novartis Pharmaceuticals Corporation, Petitioner v. HEC Pharm Co., Ltd., et al.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 17, 2023

    Justices Won't Take Up Novartis-HEC Feud Over MS Drug

    The U.S. Supreme Court on Monday rebuffed Novartis Pharmaceuticals' call for it to review a Federal Circuit ruling that invalidated the drugmaker's patent on blockbuster multiple sclerosis treatment Gilenya.

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login